designer drug found ingredient synthetic cannabis smoking blends ireland hungary germany unclear originally developed structurally related compounds corresponding analogue known potent cannabinoid agonists moderate high selectivity first published synthesis pharmacological evaluation revealed acts full agonist nm receptors however found possess weak cannabimimetic effects rats doses mgkg making less potent carboxamide analogue apica possesses potent cannabimimetic activity doses